Novotech Featured Reports

  1. Acute Myeloid Leukemia: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Gain a better understanding of the incidence, distribution, and possible control of acute myeloid leukemia (AML) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  2. Prostate Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of prostate cancer (PCa) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  3. Breast Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of breast cancer in the Asia Pacific region, the standard of care, the trial landscape, and more.

  4. Melanoma: Global Clinical Trial Landscape - Focus On Asia Pacific 5/9/2023

    Better understand the incidence, distribution, and possible control of melanoma in the Asia Pacific region, the standard of care, the trial landscape, and more.

  5. Ovarian Cancer: Global Clinical Trial Landscape - Focus On Asia Pacific 5/8/2023

    Better understand the incidence, distribution, and possible control of ovarian cancer (OC) in the Asia Pacific region, the standard of care, the trial landscape, and more.

  6. Why You Should Conduct Your Biotech And CAR-T Research In China 4/5/2023

    China is leading the world in oncology and CAR-T research. And with over a billion people and a government friendly to biotech, it’s an ideal location for international clinical trials.

  7. Designing A Global Drug Development Program To Secure FDA Approval 2/7/2023

    Global clinical trials in the Asia-Pacific region are becoming an attractive solution for young biotech companies looking to utilize their capital efficiently and secure high-quality clinical data quickly.

  8. Leveraging Global Drug Development Programs To Ensure Trial Success 2/7/2023

    Opting to take your biotech program global can help save crucial resources, produce high-quality clinical data for your therapy, and leverage unique regional advantages like region-specific indication strategies.

  9. Parkinson's Disease: Asia Pacific Clinical Trial Landscape 9/29/2022

    In the coming years, the global burden of Parkinson's Disease (PD) is expected to rise. The number of people with PD in Asia is anticipated to exceed 6 million by 2030. Discover the factors leading to this in this report.

  10. Multiple Myeloma: Asia Pacific Clinical Trial Landscape 9/29/2022